Function and regulation of kinesin motors in cells
Function and regulation of kinesin motors in cells
批准号:
10674062
负责人:
Martin F. Engelke
金额:
$35.99万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-08-31
关键词:
BackBiochemicalCell membraneCell physiologyCellsCellular AssayChlamydomonasCiliaClassificationDevelopmentDiseaseDynein ATPaseEngineeringGenome engineeringIn VitroIntracellular TransportKinesinLengthMaintenanceMastigophoraMicroscopyMicrotubulesMitotic spindleModelingMotorNasal cavityOrganellesPhysiologyProcessProtein EngineeringProteinsRegulationRenal tubule structureResearch PersonnelResolutionSensoryStimulusStructureSystemTimeTissuesTrainingTubulinUrineWorkbasechemical propertyciliopathyexperimental studyhuman diseasemorphogensnovelphysical propertyrecruittherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Microtubule-based kinesin and dynein motors drive a plethora of cellular processes, including
intracellular transport of cellular cargo, assembly and function of the mitotic spindle, and ciliary function. While
the chemical and physical properties of kinesins are well studied in vitro, much less is known about the specific
function and regulation of kinesin motors in cells. The KIF3A/KIF3B/KAP motor, subsequently referred to as
kinesin-2, drives intracellular transport of various cargos and is also essential for intraflagellar transport (IFT),
a specialized transport inside eukaryotic cilia. Cilia are protrusions of the plasma membrane that are
supported by a specialized microtubule structure called the axoneme. Primary cilia are solitary and immotile
cilia that sense various stimuli in a tissue-specific manner. They can, for instance, sense the presence of
morphogens during development, odorants in the nasal cavity, or the strength of urine flow in kidney tubules.
Given these essential sensory functions, it is not surprising that ciliary malfunction underlies many diseases
that are collectively classified as ciliopathies.
During IFT, large protein assemblies called IFT trains are continuously transported within cilia. The
IFT trains are loaded with specific cargo at the ciliary base and subsequently recruit kinesin-2 motors for
transport along the axonemal microtubules to the tip of the cilium. There, the kinesin-2 motors are released,
specific cargo is unloaded, and the trains are remodeled for subsequent transport back to the ciliary base by
dynein-2. It is well established that the loss of any subunit of the kinesin-2 motor leads to the complete
absence of cilia, and interference with IFT leads to the disappearance of already established cilia. From
experiments with the single-celled flagellate Chlamydomonas we know that tubulin influx into cilia via IFT is
modulated as a function of cilium length. Based on this finding several recent models aimed at explaining the
impact of IFT on cilium length and cilium maintenance attribute high importance to the ciliary tubulin
concentration. However, the change in tubulin concentration in these models cannot explain all experimental
findings and it is likely that other aspects of IFT in addition to tubulin import are important for ciliary length and
structure. Thus, the importance of IFT for the ciliary structure and the regulation of kinesin-2 motor for IFT is
only incompletely understood, especially in mammalian systems. In this proposal, we will use a combination
of biochemical & cellular assays, protein & genome engineering, and high-resolution microscopy to study how
kinesin-2 is regulated for IFT and to delineate the impact of kinesin-2 driven IFT on the structure of mammalian
cilia. At the center of our approach are engineered kinesin proteins whose activity can be precisely regulated
in time and space externally by the investigator. The work laid out in this proposal will shed light on the function
and regulation of kinesin motors in mammalian cilia and thereby promote the development of therapies aimed
at alleviating or curing motor protein-associated human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Function and regulation of kinesin motors in cells
-
批准号:10501529
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2022
-
负责人:Martin F. Engelke
-
依托单位:
Genetic repair of muscular degeneration associated with Duchenne muscular dystrophy
-
批准号:10439290
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2016
-
负责人:Martin F. Engelke
-
依托单位:
海外基金